1. Home
  2. RGTI vs GRFS Comparison

RGTI vs GRFS Comparison

Compare RGTI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTI

Rigetti Computing Inc.

HOLD

Current Price

$19.01

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.60

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTI
GRFS
Founded
2013
1940
Country
United States
Spain
Employees
164
25247
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGTI
GRFS
Price
$19.01
$7.60
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$30.78
$10.15
AVG Volume (30 Days)
26.2M
577.4K
Earning Date
05-11-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$225.06
$4.49
Revenue Next Year
$99.56
$6.42
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$10.18
$7.36
52 Week High
$58.15
$11.14

Technical Indicators

Market Signals
Indicator
RGTI
GRFS
Relative Strength Index (RSI) 56.35 35.69
Support Level $14.18 $7.39
Resistance Level $19.55 $9.78
Average True Range (ATR) 1.41 0.22
MACD 0.18 -0.06
Stochastic Oscillator 66.00 3.80

Price Performance

Historical Comparison
RGTI
GRFS

About RGTI Rigetti Computing Inc.

Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: